Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abraxane White Paper Distribution At ASCO Draws FDA Advertising Letter

Feb 02 2012

• By Brenda Sandburg

Related Content

Despite Celgene's Abraxane Stock, Trading Earn-Outs Is The Exception Not The Rule

Nov 01 2010

White Paper Is Actually Branded Promotion, FDA Tells Ipsen

Nov 09 2010

Celgene Moves Into Solid Tumors With $2.9 Billion Abraxis Acquisition

Jul 05 2010

Related Companies

Bristol Myers Squibb Company

Ipsen SA

Additional Topics

United States Regulation Advertising, Marketing & Sales BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window